James P. Scanlan Attorney at Law Washington, DC, USA

Slides:



Advertisements
Similar presentations
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Advertisements

2008 Joint Statistical Meetings Denver, Colorado, August 2-7, 2008 Evaluating the Size of Differences Between Group Rates in Settings of Different Overall.
American Public Health Association 138 th Annual Meeting Denver, Colorado Nov. 6-10, 2010 The Emerging European Acceptance of Scanlan’s Rule in Health.
Race and Socioeconomic Differences in Health Behavior Trajectories Across the Adult Life Course ACKNOWLEDGEMENTS This research was supported by the grant.
The Misunderstood Relationship Between Declining Mortality and Increasing Racial and Social Disparities in Mortality Rates James P. Scanlan (Presented.
RELATIVE RISK ESTIMATION IN RANDOMISED CONTROLLED TRIALS: A COMPARISON OF METHODS FOR INDEPENDENT OBSERVATIONS Lisa N Yelland, Amy B Salter, Philip Ryan.
2009 Joint Statistical Meetings Washington, DC August 1-6, 2009 Interpreting Differential Effects in Light of Fundamental Statistical Tendencies James.
EPIDEMIOLOGY AND BIOSTATISTICS DEPT Esimating Population Value with Hypothesis Testing.
Review for Exam 2 Some important themes from Chapters 6-9 Chap. 6. Significance Tests Chap. 7: Comparing Two Groups Chap. 8: Contingency Tables (Categorical.
Measuring Health and Healthcare Disparities 2013 Research Conference of the Federal Committee on Statistical Methodology Washington, DC, Nov. 4-6, 2013.
Measurement Problems in the National Healthcare Disparities Report American Public Health Association 135 th Annual Meeting & Exposition, Nov. 3-7,2007,
Biostatistics Case Studies 2005 Peter D. Christenson Biostatistician Session 4: Taking Risks and Playing the Odds: OR vs.
Kansas Department of Health and Environment Center for Health Disparities 2008 Health Disparities Conference Topeka, Kansas, Apr. 1, 2008 Measuring Health.
© 2008 Morningstar, Inc. All rights reserved. 3/1/2008 LCN Portfolio Performance.
Understanding Variations in Group Differences that are the Results of Variations in the Prevalence of an Outcome American Public Health Association 134.
16 th Nordic Demographic Symposium Helsinki, Finland, 5-7 June 2008 Measures of Health Inequalities that are Unaffected by the Prevalence of an Outcome.
Royal Statistical Society 2009 Conference Edinburgh, Scotland 7-11 September 2009 Measuring Health Inequalities by an Approach Unaffected by the Overall.
7 th International Conference on Health Policy Statistics, Philadelphia, PA, January 17-18, 2008 Can We Actually Measure Health Disparities? James P. Scanlan.
Analysis of Qualitative Data Dr Azmi Mohd Tamil Dept of Community Health Universiti Kebangsaan Malaysia FK6163.
Measuring Healthcare Disparities Third North American Congress of Epidemiology Montreal, Quebec, June 21-24, 2011 James P. Scanlan Attorney at Law Washington,
British Society for Population Studies 2007 Annual Conference St. Andrews, Scotland, Sep 2007 Methodological Issue in Comparing the Size of Differences.
Dr.Theingi Community Medicine
Methods of Presenting and Interpreting Information Class 9.
Statistics & Evidence-Based Practice
CROSS SECTIONAL STUDIES
Lecture #8 Thursday, September 15, 2016 Textbook: Section 4.4
Types of risk Market risk
Statistics 200 Lecture #9 Tuesday, September 20, 2016
Statistics 200 Lecture #7 Tuesday, September 13, 2016
Health Disparities and Their Public Health Solutions
Mesfin S. Mulatu, Ph.D., M.P.H. The MayaTech Corporation
Chapter 9 Audit Sampling: An Application to Substantive Tests of Account Balances McGraw-Hill/Irwin ©2008 The McGraw-Hill Companies, All Rights Reserved.
Fred Pampel University of Colorado, Boulder
Chapter 7 Sampling and Sampling Distributions
Pancreas Transplantation Committee
The Misinterpretation of Health Inequalities in the United Kingdom
Risk Mgt and the use of derivatives
The Misinterpretation of Health Inequalities in Nordic Countries
Relative Values.
Wenliang Hou and Geoffrey T. Sanzenbacher
بسم الله الرحمن الرحيم COHORT STUDIES.
Hypothesis Testing Review
Sampling Distributions
Chapter 10 Two-Sample Tests.
Factors associated with frequency of responding to electronic surveys among students attending a large minority-serving university: The Student Behavioral.
Influenza Vaccine Effectiveness Against Pediatric Deaths:
James P. Scanlan Attorney at Law Washington, DC, USA
Types of risk Market risk
Dan Goldhaber1,2, Vanessa Quince2, and Roddy Theobald1
Examples and SAS introduction: -Violations of the rare disease assumption -Use of Fisher’s exact test January 14, 2004.
”Thinking Quantitatively”
Essential Statistics Introduction to Inference
Cerdá M, Wall M, Feng T, et al
Data Characterization
Evaluating Effect Measure Modification
Part 3: Weighting Estimation Samples Frank Porell
Measures of risk and association
Increasing Disparity: The Scanlan Effect
Module appendix - Attributable risk
Travel-associated non-typhoidal salmonellosis: geographical and seasonal differences and serotype distribution  K. Ekdahl, B. de Jong, R. Wollin, Y. Andersson 
STA 291 Summer 2008 Lecture 18 Dustin Lueker.
9th International Conference on Health Policy Statistics
Who’s cooking? Analysis of food preparation time in the 2003 ATUS
Logistic Regression.
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients by Jenna Sopfe, Laura Pyle, Amy K.
CROSS SECTIONAL STUDIES
Columbia University, Department of Biostatistics
Receipt of Adjuvant Endometrial Cancer Treatment According to Race NRG Oncology/Gynecologic Oncology Group (GOG) 210 Study Ashley Felix, PhD, MPH Assistant.
STA 291 Spring 2008 Lecture 17 Dustin Lueker.
Measuring Health Disparities in Healthy People 2010
Presentation transcript:

James P. Scanlan Attorney at Law Washington, DC, USA jps@jpscanlan.com American Public Health Association 136th Annual Meeting & Exposition, San Diego, CA, Oct. 25-29, 2008 Approaches to Measuring Health Disparities that are Unaffected by the Overall Prevalence of an Outcome James P. Scanlan Attorney at Law Washington, DC, USA jps@jpscanlan.com

Presenter Disclosures James P. Scanlan (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months: No relationship to disclose

Subjects 1. The problem with standard binary measures of differences between rates (relative differences, absolute differences, odds ratios): that all exhibit patterns of correlation with overall prevalence (i.e., among other things, they tend to change as overall prevalence changes) 2. An alternative approach that avoids the problem with standard measures: a measure that does not change as overall prevalence changes

References (available on jpscanlan.com) Measuring Health Disparities Page 90 references (articles, presentations, on-line commentary) Solutions Tab Solutions Database Tab (downloadable database) Scanlan’s Rule Page Can We Actually Measure Health Disparities (Chance 2006) Race and Mortality (Society 2000) APHA 2007 Presentation Addendum

Patterns by Which Binary Measures Tend to Change as the Overall Prevalence of an Outcome Changes – Scanlan’s Rules SR1: The rarer an outcome, the greater tends to be the relative difference in rates of experiencing it and the smaller tends to be the relative difference in rates of avoiding it (aka Heuristic Rule X or Interpretative Rule 1; see Bauld, Day, Judge, 2008) SR2: As an outcome changes in overall prevalence, the odds ratio tends to change in the same direction as the larger of the two relative differences and the absolute difference tends to change in the same direction as the smaller of the two relative differences ─ where the numerators are reversed on the two risk ratios (see Semantic Issues tab on Scanlan’s Rule page)

Fig 1. Ratio of (1) Advantaged Group (AG) Success Rate to Disadvantaged Group (DG) Success Rate at Various Cutoffs Defined by AG Success Rate

Fig 2. Ratios of (1) AG Success Rate to DG Success Rate and (2) DG Fail Rate to AG Fail Rate

Fig 3. Ratios of (1) AG Success Rate to DG Success Rate, (2) DG Fail Rate to AG Fail Rate, and (3) DG Fail Odds to AG Fails Odds

Fig 4. Ratios of (1) AG Success Rate to DG Success Rate, (2) DG Fail Rate to AG Fail Rate, and (3) DG Fail Odds to AG Fails Odds; and Absolute Diff Between Rates

Table 1 Illustration of the Problem and Intimation of the Solution (in terms of a favorable outcome increasing in overall prevalence) Period Yr 1 Yr 2 Yr 3 Yr 4 AG Rate 40% 58% 76% 94% DG Rate 23% 39% 58% 85% Measures of Difference (Blue=decrease; Red=increase) Ratio 1 1.74 1.45 1.31 1.11 Ratio 2 1.28 1.49 1.75 2.50 Odds Ratio 2.23 2.16 2.29 2.76 Absol Diff .17 .19 .18 .09 EES (z) .50 .50 .50 .50

Estimated Effect Size (EES) Difference between means of hypothesized underlying distributions of risks of experiencing an outcome, in terms of percentage of a standard deviation, assuming normality of the distributions

Table 2 Simplified Illustration of the Solution (in terms of a favorable outcome increasing in overall prevalence) Period Yr 1 Yr 2 AG Rate 40% 58% DG Rate 23% 40% Measures of Difference Change Direction Ratio 1 1.74 1.43 Increase Ratio 2 1.28 1.45 Decrease Odds Ratio 2.23 2.07 Decrease Absol Diff .17 .18 Increase EES (z) .50 .47 Decrease

Table 3 Illustration of Meaning of Various Ratios at Different Prevalence Levels DGFailRate AGFailRate EES 1.2 60.0% 50.0% 0.26 18.4% 15.4% 0.12 1.5 75.0% 0.68 45.0% 30.0% 0.39 2.0 40.0% 20.0% 0.59 10.0% 0.44 1.0% 0.5% 0.24 2.5 24.2% 9.7% 0.60 7.4% 2.9% 3.0 44.0% 14.7% 0.90 14.4% 4.8% 2.7% 0.9%

Table 4 Illustration Based on Morita et. al Table 4 Illustration Based on Morita et. al. (Pediatrics 2008) Data on Black and White Hepatitis B Vaccination Rates Pre and Post School-Entry Vaccination Requirement (see Morita Comment) Period Grade Year WhRt BlRt Fav Ratio Adv AbsDf EES Pre Requ 5 (Y1) 1996 8% 3% 2.67 1.05 0.05 0.47 Post (Y2) 1997 46% 33% 1.39 1.24 0.13 0.34 9 32% 1.44 1.26 0.14 0.37 89% 84% 1.06 1.45 0.24

Table 5 Illustrations Based on Escarce and McGuire (AJPH 2004) Data on White and Black Coronary Procedure Rates, 1986, 1997 (see Escarce Comment) Proc Year Wh Rt Bl Rt Fav Ratio Adv AbsDf EES Angrm (Y1) 1986 0.86% 0.43% 1.99 1.05 0.04 0.25 (Y2) 1997 2.28% 1.61% 1.42 1.09 0.07 0.14 Angpls 0.10% 0.03% 3.09 1.01 0.01 0.32 0.26% 0.16% 1.61 0.15 ArtByp 0.31% 0.08% 3.78 1.02 0.02 0.41 0.59% 2.25 1.03 0.03 0.27

Table 6: Illustration Based on Seghal (JAMA 2003) Data on Black and White Rates of Adequate Hemodialysis, 1993 and 2000 (see APHA 2007 Addendum) Year W B Fav Ratio Adv AbsDf EES 1993 46% 36% 1.28 1.19 0.10 0.26 2000 87% 84% 1.04 1.23 0.03 0.14

Problems with the Solution Always practical issues (we do not really know the shape of the underlying distributions) Sometimes fundamental issues (e.g., where we know distributions are not normal because they are truncated portions of larger distributions, see Bostrom Comment; cf. ICPHS 2008, Fig. 6 Absolute minimum issue (Bostrom Comment, BSPS 2006, Race and Mortality)

Conclusion If we are mindful of the problems, the approach provides a framework for cautiously appraising the size of differences between rates. Regardless of problems, the approach is superior to reliance on standard binary measures of differences between rates without regard to the way those measures tend to be correlated with the overall prevalence of an outcome.

Implementation Formula to derive EES? Database downloadable from jpscanlan.com

Example of 8 of 76,960 rows in table downloadable from jpscanlan.com EES AG Fail DG Fail 0.60 0.50399 0.72907 0.5 0.72575 0.72241 0.49601 0.71905 0.30 0.62172 0.61791 0.6141 0.61026

Supp Table 1: Illustration Based on Hetemaa et al Supp Table 1: Illustration Based on Hetemaa et al. (JECH 2003) Data on Finnish Revascularization Rates, 1988 and 1996, by Income Group (see Hetemaa Comment 1, Hetemaa Comment 2) Gender Year AG RevRt LowInc Fav Ratio Adv AbsDf EES M (Y1) 1988 17.9% 8.3% 2.16 1.12 .096 0.48 (Y2) 1996 41.2% 25.4% 1.63 1.27 .159 0.44 F 10.0% 3.7% 2.70 1.07 .063 0.51 30.8% 17.1% 1.80 1.20 .137 0.45

Supp Table 2: Illustration Based on Laaksonen et al Supp Table 2: Illustration Based on Laaksonen et al. (JECH 2008) Data on Mortality Rates of Finnish Men by Owner or Renter Status (see follow-up on Bostrom Comment) Age OwnMort RentMort AdvRatio FavRatio EES 40–44 1.46% 4.26% 2.91 1.03 0.46 45–49 2.46% 6.04% 2.45 1.04 0.42 50–54 3.68% 9.68% 2.63 1.07 0.49 55–59 5.62% 13.09% 2.33 1.09 0.47 60–64 8.88% 19.89% 2.24 1.14 0.5 65–69 14.33% 29.38% 2.05 1.21 0.53 70–74 24.62% 41.85% 1.70 1.30 0.48 75–79 36.55% 57.75% 1.58 1.50 0.56

Supp Table 3 Illustration from Valkonen et al Supp Table 3 Illustration from Valkonen et al. (JEPH 2000) Based on All Cause Mortality in Finland for Three Time Periods Gender Period AGMort DGMort AdvRatio FavRatio EES M 1981-85 0.64% 0.96% 1.50 1.00321 0.15 1986-90 0.53% 0.93% 1.75 1.00404 0.21 1991-95 0.46% 0.85% 1.86 1.00395 0.22 F 0.29% 0.35% 1.21 1.00060 0.07 0.26% 0.36% 1.36 1.00095 0.11 0.24% 1.48 1.00113 0.14 f